Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)
Condition(s):Nonalcoholic SteatohepatitisLast Updated:February 22, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Nonalcoholic SteatohepatitisLast Updated:February 22, 2023Withdrawn
Condition(s):Nonalcoholic Steatohepatitis (NASH)Last Updated:August 31, 2022Terminated
Condition(s):Non-Alcoholic SteatohepatitisLast Updated:December 20, 2022Completed
Condition(s):Non-Alcoholic SteatohepatitisLast Updated:August 25, 2015Withdrawn
Condition(s):Nonalcoholic SteatohepatitisLast Updated:February 28, 2024Active, not recruiting
Condition(s):Non-Alcoholic Steatohepatitis (NASH)Last Updated:January 3, 2024Recruiting
Condition(s):Non-alcoholic Steatohepatitis (NASH)Last Updated:March 19, 2024Completed
Condition(s):•Non-alcoholic Steatohepatitis (NASH)Last Updated:September 26, 2013Unknown status
Condition(s):NON-ALCOHOLIC STEATOHEPATITISLast Updated:March 6, 2024Recruiting
Condition(s):Non-Alcoholic Steatohepatitis (NASH)Last Updated:February 23, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.